Holen Sie sich die Stockscreener-App
0.8625
61.52%
0.3285
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BCLI?
Forum
Prognose
Aktiensplit
Brainstorm Cell Therapeutics Inc Aktie (BCLI) Neueste Nachrichten
Brainstorm Cell Therapeutics Inc. (BCLI) Stock Price | Live Quotes & Charts | OTCQB - StocksToTrade
Brainstorm Cell Therapeutics 2025 10-K: $0.0M Revenue, $(1.11) EPS - TradingView
ALS therapy pivot: BrainStorm (BCLI) pulls BLA, wins FDA SPA for new Phase 3b - Stock Titan
Brainstorm Cell Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
BrainStorm Cell (OTCQB: BCLI) posts 2025 loss, tight cash and equity deficit - Stock Titan
BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update - chartmill.com
Growth Value: What is the target price for Brainstorm Cell Therapeutics Inc stock2026 Year in Review & Capital Efficient Trade Techniques - baoquankhu1.vn
Gap Down: Whats the profit margin of Brainstorm Cell Therapeutics Inc2026 Macro Moves & Daily Stock Momentum Reports - baoquankhu1.vn
Pullback Watch: Is Brainstorm Cell Therapeutics Inc in a long term uptrend2026 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Breakout Zone: Does Brainstorm Cell Therapeutics Inc have declining or rising EPS2026 Breakouts & Reliable Breakout Stock Forecasts - baoquankhu1.vn
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn® - Nasdaq
If You Invested $1,000 in Brainstorm Cell Therapeutics I (BCLI) - Stock Titan
Tech Rally: Is Brainstorm Cell Therapeutics Inc stock risky to hold nowEarnings Performance Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 Delveinsight Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals - menafn.com
Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals - Barchart
Insider Buy: Is Olema Pharmaceuticals Inc forming bullish engulfing patterns2026 Short Interest & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Weekly Recap: How do insiders feel about Brainstorm Cell Therapeutics Inc2026 Short Interest & Community Trade Idea Sharing - baoquankhu1.vn
Maxim Group downgrades Brainstorm Cell Therapeutics (BCLI) - MSN
S P Trends: Is Brainstorm Cell Therapeutics Inc in a long term uptrend2025 Top Gainers & Weekly Breakout Watchlists - baoquankhu1.vn
BCLI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Brainstorm Cell Therapeutics Adds Shares to Equity Incentive Plan - TipRanks
Brainstorm Cell Therapeutics Arranges Up to $1.0 Million Private Placement at $0.60, Adds Warrants - TradingView
Brainstorm Cell (BCLI) launches $1M private placement and adds 5.5M incentive shares - Stock Titan
BrainStorm Cell Therapeutics to Provide Update on NurOwn Program - GuruFocus
Brainstorm Cell secures second $1M private placement this month By Investing.com - Investing.com Nigeria
Brainstorm Cell secures second $1M private placement this month - Investing.com
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February - Nasdaq
Aug Outlook: Whats the profit margin of Brainstorm Cell Therapeutics IncPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
BCLI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Brainstorm Cell Therapeutics Inc. announced that it expects to receive $1 million in funding - marketscreener.com
Brainstorm Cell secures $1M strategic financing - MSN
Brainstorm Cell raises $1M in private placement at premium pricing - Investing.com Nigeria
Loss Report: Is Brainstorm Cell Therapeutics Inc stock undervalued right now2025 Short Interest & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Published on: 2026-02-20 18:26:53 - mfd.ru
Brainstorm Cell Therapeutics announces $1 million strategic financing at premium to market - marketscreener.com
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market - TradingView
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market - Financial Times
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - The Manila Times
Setup Watch: What is the target price for Brainstorm Cell Therapeutics Inc stockTrade Volume Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn
Market Outlook: Is Brainstorm Cell Therapeutics Inc. stock risky to hold nowJuly 2025 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Tech Rally: Can Brainstorm Cell Therapeutics Inc be the next market leaderJuly 2025 Volume & Capital Protection Trade Alerts - baoquankhu1.vn
Brainstorm Cell Therapeutics Announces New Private Placement Financing - The Globe and Mail
What is the target price for Brainstorm Cell Therapeutics Inc. stockJuly 2025 Update & Fast Gain Swing Trade Alerts - mfd.ru
Brainstorm Cell Therapeutics Signs Securities Purchase Agreement With Accredited Investor - TradingView
Is Brainstorm Cell Therapeutics Inc. in a long term uptrend2025 Investor Takeaways & Expert Curated Trade Setup Alerts - mfd.ru
What’s the profit margin of Brainstorm Cell Therapeutics Inc.Trade Entry Report & Community Consensus Stock Picks - mfd.ru
BrainStorm Cell Therapeutics Submits Type A Meeting Request to U.S. Food and Drug Administration - Nasdaq
Biotech Stocks To Keep An Eye On – January 22nd - Defense World
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Hits New 52-Week HighHere's What Happened - MarketBeat
Biotech Stocks To Keep An Eye OnJanuary 22nd - MarketBeat
Weekly Earnings: Is Brainstorm Cell Therapeutics Inc in a long term uptrend2025 Price Momentum & Real-Time Volume Analysis - baoquankhu1.vn
Amyotrophic Lateral Sclerosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharma - The Globe and Mail
What Wall Street predicts for Brainstorm Cell Therapeutics Inc. stock priceJuly 2025 Snapshot & Fast Exit and Entry Trade Guides - Улправда
Brainstorm Cell Therapeutics Secures New Convertible Debt Financing - TipRanks
Brainstorm Cell Therapeutics Signs Multiple Financing Agreements - TradingView — Track All Markets
Brainstorm Cell Therapeutics (BCLI) raises cash via new unsecured convertible notes - Stock Titan
Why retail investors favor Brainstorm Cell Therapeutics Inc. stockWeekly Trend Summary & Long-Term Growth Plans - Улправда
0.49%
1.47%
Kapitalisierung:
|
Volumen (24h):